Extracellular Vesicles Derived from Mesenchymal Stem Cells - a Novel Therapeutic Tool in Infectious Diseases

Overview

Journal Inflamm Regen

Publisher Biomed Central

Date 2023 Feb 28

PMID 36849892

Authors

Tasaduq Manzoor

Afnan Saleem

Nida Farooq

Lateef Ahmad Dar

Junaid Nazir

Sahar Saleem

Sameena Ismail

Mudasir Bashir Gugjoo

Parvaiz A Shiekh

Syed Mudasir Ahmad

Affiliations

Soon will be listed here.

Abstract

Extracellular vesicles (EVs) are nano-sized lipid-bilayer encapsulated vesicles produced by the cells. These EVs are released into the surrounding space by almost all cell types. The EVs help in intercellular communication via their payloads which contain various proteins, lipids, and nucleic acids generated from the donor cells and allow for synergistic responses in surrounding cells. In recent years, EVs have been increasingly important in treating infectious diseases, including respiratory tract infections, urinary tract infections, wound infections, sepsis, and intestinal infections. Studies have confirmed the therapeutic value of mesenchymal stem cell-derived EVs (MSC-EVs) for treating infectious diseases to eliminate the pathogen, modulate the resistance, and restore tissue damage in infectious diseases. This can be achieved by producing antimicrobial substances, inhibiting pathogen multiplication, and activating macrophage phagocytic activity. Pathogen compounds can be diffused by inserting them into EVs produced and secreted by host cells or by secreting them as microbial cells producing EVs carrying signalling molecules and DNA shielding infected pathogens from immune attack. EVs play a key role in infectious pathogenesis and hold great promise for developing innovative treatments. In this review, we discuss the role of MSC-EVs in treating various infectious diseases.

Citing Articles

Biodistribution and persistence of human umbilical cord-derived mesenchymal stem cells in NCG mice: a comparative study.

Liu G, Wang H, Li X, Mi Y, Zhang C, Chen Y Future Sci OA. 2025; 11(1):2471723.

PMID: 40035430 PMC: 11881841. DOI: 10.1080/20565623.2025.2471723.

Exosome-based miRNA delivery: Transforming cancer treatment with mesenchymal stem cells.

Balaraman A, Babu M, Afzal M, Sanghvi G, M M R, Gupta S Regen Ther. 2025; 28:558-572.

PMID: 40034540 PMC: 11872554. DOI: 10.1016/j.reth.2025.01.019.

Enhanced Multi-Model Deep Learning for Rapid and Precise Diagnosis of Pulmonary Diseases Using Chest X-Ray Imaging.

Kumar R, Pan C, Lin Y, Yow-Ling S, Chung T, Janesha U Diagnostics (Basel). 2025; 15(3).

PMID: 39941178 PMC: 11817112. DOI: 10.3390/diagnostics15030248.

Exosomes in nanomedicine: a promising cell-free therapeutic intervention in burn wounds.

Manzoor T, Farooq N, Sharma A, Shiekh P, Hassan A, Dar L Stem Cell Res Ther. 2024; 15(1):355.

PMID: 39385310 PMC: 11462792. DOI: 10.1186/s13287-024-03970-3.

Wharton's Jelly mesenchymal stem cell-derived extracellular vesicles induce liver fibrosis-resolving phenotype in alternatively activated macrophages.

Torabi S, Zarrabi M, Shekari F, Poorkazem H, Lotfinia M, Bencina S J Cell Mol Med. 2024; 28(18):e18507.

PMID: 39288445 PMC: 11407755. DOI: 10.1111/jcmm.18507.

References

Blazquez R, Sanchez-Margallo F, de la Rosa O, Dalemans W, Alvarez V, Tarazona R . Immunomodulatory Potential of Human Adipose Mesenchymal Stem Cells Derived Exosomes on in vitro Stimulated T Cells. Front Immunol. 2014; 5:556. PMC: 4220146. DOI: 10.3389/fimmu.2014.00556. View

Mendt M, Kamerkar S, Sugimoto H, McAndrews K, Wu C, Gagea M . Generation and testing of clinical-grade exosomes for pancreatic cancer. JCI Insight. 2018; 3(8). PMC: 5931131. DOI: 10.1172/jci.insight.99263. View

Takahashi Y, Nishikawa M, Shinotsuka H, Matsui Y, Ohara S, Imai T . Visualization and in vivo tracking of the exosomes of murine melanoma B16-BL6 cells in mice after intravenous injection. J Biotechnol. 2013; 165(2):77-84. DOI: 10.1016/j.jbiotec.2013.03.013. View

Haraszti R, Didiot M, Sapp E, Leszyk J, Shaffer S, Rockwell H . High-resolution proteomic and lipidomic analysis of exosomes and microvesicles from different cell sources. J Extracell Vesicles. 2016; 5:32570. PMC: 5116062. DOI: 10.3402/jev.v5.32570. View

Pacienza N, Lee R, Bae E, Kim D, Liu Q, Prockop D . Macrophage Assay Predicts the Anti-inflammatory Potential of Exosomes from Human Mesenchymal Stromal Cells. Mol Ther Methods Clin Dev. 2019; 13:67-76. PMC: 6350420. DOI: 10.1016/j.omtm.2018.12.003. View

Nguyen T, Duong C, Nguyen X, Than U . Mesenchymal Stem Cell-Derived Extracellular Vesicles for Osteoarthritis Treatment: Extracellular Matrix Protection, Chondrocyte and Osteocyte Physiology, Pain and Inflammation Management. Cells. 2021; 10(11). PMC: 8616200. DOI: 10.3390/cells10112887. View

Hanson P, Cashikar A . Multivesicular body morphogenesis. Annu Rev Cell Dev Biol. 2012; 28:337-62. DOI: 10.1146/annurev-cellbio-092910-154152. View

Mehta R, Cerda J, Burdmann E, Tonelli M, Garcia-Garcia G, Jha V . International Society of Nephrology's 0by25 initiative for acute kidney injury (zero preventable deaths by 2025): a human rights case for nephrology. Lancet. 2015; 385(9987):2616-43. DOI: 10.1016/S0140-6736(15)60126-X. View

Phinney D, Di Giuseppe M, Njah J, Sala E, Shiva S, St Croix C . Mesenchymal stem cells use extracellular vesicles to outsource mitophagy and shuttle microRNAs. Nat Commun. 2015; 6:8472. PMC: 4598952. DOI: 10.1038/ncomms9472. View

10.

Van Puyvelde S, Deborggraeve S, Jacobs J . Why the antibiotic resistance crisis requires a One Health approach. Lancet Infect Dis. 2017; 18(2):132-134. DOI: 10.1016/S1473-3099(17)30704-1. View

11.

Ullah I, Subbarao R, Rho G . Human mesenchymal stem cells - current trends and future prospective. Biosci Rep. 2015; 35(2). PMC: 4413017. DOI: 10.1042/BSR20150025. View

12.

Ramirez-Bajo M, Martin-Ramirez J, Bruno S, Pasquino C, Banon-Maneus E, Rovira J . Nephroprotective Potential of Mesenchymal Stromal Cells and Their Extracellular Vesicles in a Murine Model of Chronic Cyclosporine Nephrotoxicity. Front Cell Dev Biol. 2020; 8:296. PMC: 7214690. DOI: 10.3389/fcell.2020.00296. View

13.

Yin K, Wang S, Zhao R . Exosomes from mesenchymal stem/stromal cells: a new therapeutic paradigm. Biomark Res. 2019; 7:8. PMC: 6450000. DOI: 10.1186/s40364-019-0159-x. View

14.

Feng R, Ullah M, Chen K, Ali Q, Lin Y, Sun Z . Stem cell-derived extracellular vesicles mitigate ageing-associated arterial stiffness and hypertension. J Extracell Vesicles. 2020; 9(1):1783869. PMC: 7480600. DOI: 10.1080/20013078.2020.1783869. View

15.

Khatri M, Richardson L, Meulia T . Mesenchymal stem cell-derived extracellular vesicles attenuate influenza virus-induced acute lung injury in a pig model. Stem Cell Res Ther. 2018; 9(1):17. PMC: 5789598. DOI: 10.1186/s13287-018-0774-8. View

16.

Nagaishi K, Mizue Y, Chikenji T, Otani M, Nakano M, Konari N . Mesenchymal stem cell therapy ameliorates diabetic nephropathy via the paracrine effect of renal trophic factors including exosomes. Sci Rep. 2016; 6:34842. PMC: 5056395. DOI: 10.1038/srep34842. View

17.

Budnik V, Ruiz-Canada C, Wendler F . Extracellular vesicles round off communication in the nervous system. Nat Rev Neurosci. 2016; 17(3):160-72. PMC: 4989863. DOI: 10.1038/nrn.2015.29. View

18.

Gao F, Zuo B, Wang Y, Li S, Yang J, Sun D . Protective function of exosomes from adipose tissue-derived mesenchymal stem cells in acute kidney injury through SIRT1 pathway. Life Sci. 2020; 255:117719. DOI: 10.1016/j.lfs.2020.117719. View

19.

Casado-Diaz A, Quesada-Gomez J, Dorado G . Extracellular Vesicles Derived From Mesenchymal Stem Cells (MSC) in Regenerative Medicine: Applications in Skin Wound Healing. Front Bioeng Biotechnol. 2020; 8:146. PMC: 7062641. DOI: 10.3389/fbioe.2020.00146. View

20.

Meehan B, Rak J, Di Vizio D . Oncosomes - large and small: what are they, where they came from?. J Extracell Vesicles. 2016; 5:33109. PMC: 5040817. DOI: 10.3402/jev.v5.33109. View